| Title: | Bapineuzumab captures the N-terminus of the Alzheimer's disease amyloid-beta peptide in a helical conformation |
| Authors: | Miles, LA Crespi, GAN Doughty, L Parker, MW |
| Issue Year: | 2013 |
| Publisher | NATURE PUBLISHING GROUP |
| Series | SCIENTIFIC REPORTS: 3(): - |
| Abstract | Bapineuzumab is a humanized antibody developed by Pfizer and Johnson & Johnson targeting the amyloid (A beta) plaques that underlie Alzheimer's disease neuropathology. Here we report the crystal structure of a Fab-A beta peptide complex that reveals Bapineuzumab surprisingly captures A beta in a monomeric helical conformation at the N-terminus. Microscale thermophoresis suggests that the Fab binds soluble A beta(1-40) with a K-D of 89 (+/- 9) nM. The structure explains the antibody's exquisite selectivity for particular A beta species and why it cannot recognize N-terminally modified or truncated A beta peptides. |
| URI: | https://publications.svi.edu.au/publications/1722 |
| Other Identifiers | 10.1038/srep01302 |
| Publication type | Article |
| Grant ID | GNT1021645; GNT1021935 |
| Find it online | http://www.nature.com/srep/2013/130218/srep01302/pdf/srep01302.pdf |